Sarah Louden: Total Health is Now an AI-First Company
Sarah Louden, Founder and CEO of Total Health, shared a post on LinkedIn:
“Exciting News: Total Health is Now an AI-First Company!
I’m thrilled to announce that Total Health | Oncology has officially evolved into an AI-first company, embracing the future of oncology education and healthcare with cutting-edge technology.
I’ve been quietly consulting for the worlds leading AI company and slowly building and designing both off-the-shelf and customized tools for us.
Here’s what this transformation means for us and our community:
– Enhanced Learning Experiences: AI allows us to provide highly personalized educational experiences, making it easier for healthcare teams to access the latest oncology insights whenever they need them.
– Streamlined Business Processes: We’ve reimagined how we operate internally, using AI to refine recruitment, engagement, and program management processes. This means even better support for our learners, partners, and collaborators.
– Stronger Insights for Our Partners: AI allows us to offer more targeted, data-driven value for sponsors, reinforcing Total Health as a leader in oncology education.
– Founders Insights: We will launch a once a week ‘class’ for anyone interested in learning how to use various tools and building them into their business or clinical process.
This is just the beginning! As we navigate this AI-first journey, we’re excited to redefine possibilities in oncology education and business operations and continue raising the bar for the industry.”
Sarah Louden is the Founder and CEO of Total Health | Oncology. She is a committed advocate for women in business and healthcare and also serves as Chairman of the Board of Directors for the Cancer Equity Project.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023